Description
HLA-DR/DQ Genetic Testing for Mold & Biotoxin Susceptibility
Why do some people appear to become much more symptomatic than others after exposure to a water-damaged or mold-contaminated environment?
The Kashi Mold Hypersensitivity / CIRS Genetic Test examines HLA genes involved in immune recognition and identifies genetic patterns that have been associated with susceptibility to inflammatory responses following certain environmental exposures.
What Does the Test Analyze?
The panel evaluates important HLA genes, including:
HLA-DRB1 HLA-DRB3, DRB4 and DRB5 HLA-DQB1
Your results provide your HLA-DR/DQ genotype and identify patterns that have been described as potentially associated with susceptibility to mold and other biotoxin-related inflammatory responses.
Who May Consider This Test?
Testing may be considered when there is a history of exposure to a water-damaged or mold-contaminated building accompanied by persistent symptoms such as:
• Fatigue • Brain fog or difficulty concentrating • Headaches • Sinus or respiratory symptoms • Unexplained muscle or joint discomfort • Neurological symptoms • Persistent symptoms that appear related to a particular building or environment
Easy Buccal Swab — No Blood Draw
The test uses a buccal (cheek) swab, making collection simple and noninvasive.
No fasting is required.
What This Test Does NOT Measure
This is an important distinction.
The Kashi test evaluates genetic susceptibility. It does not determine whether you have been exposed to mold, measure mold or mycotoxins in your body, diagnose mold allergy, or by itself diagnose Chronic Inflammatory Response Syndrome (CIRS).
Someone can carry an HLA pattern associated with increased susceptibility and never develop illness.
For evaluation of actual mycotoxin exposure or mold allergy, other laboratory testing may be more appropriate.
